As standard therapy for prostate cancer, radical prostatectomy (RP) causes cavernous nerve injury and increases fibrosis and hypoxia-induced penile structural alterations. This study aimed to determine the potential beneficial effects of adipose-derived stem cells (ADSCs) and L-arginine alone or in combination on the penile erection of a rat model of erectile dysfunction (ED) caused by bilateral cavernous nerve (CN) transection. Male rats (n=35) were randomized into five groups: Sham-operated; CN transection (4-wk); CN transection plus ADSCs (1x106 cells by intracavernosal injection); CN transection plus L-arginine (4wk, 10 mg/kg/day, oral); and ADSCs combined with L-arginine in CN transection. In vivo erectile responses and in vitro relaxant responses were measured. Western blot and immunohistochemistry analyses were used to determine the expression and localization of endothelial nitric oxide synthases (eNOS), neuronal NOS (nNOS), transforming growth factor-beta 1 (TGF-1), hypoxia-inducible factor-1 (HIF-1), and apoptosis markers (Bax and Bcl-2). The ratio of smooth muscle to collagen and nerve regeneration was calculated using Masson's trichrome and nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase staining. The combined treatment restored diminished erectile responses, endothelium-dependent acetylcholine, and electrical field stimulation-induced relaxation of the corpus cavernosum in rats with CN transection, whereas either monotherapy produced only partial improvements. All treatment regimens restored increases in the protein expression of HIF-1 and Bax in rodents with CN transection. The decrease in smooth muscle mass and NADPH-diaphorase-positive nerve fibers was partially ameliorated by monotherapy, whereas combined therapy led to recovery. These findings indicate that combined treatment with ADSCs and L-arginine may restore erectile function in rodents with CN transection by inhibiting hypoxia-induced neurotoxicity and preserving endothelium function and smooth muscle content.
Medicinal plants are increasingly used to treat skin diseases and as cosmetics. Türkiye has a rich diversity of medicinal flora, and patients have a choice of ethnomedicines to manage various dermatology problems. This comprehensive review aims to summarize the primary information available on the dermatological properties of medicinal plants in Türkiye and provide a baseline for the detection of new plant species having efficacy against skin conditions. In this review, clinical and experimental data were researched using relevant search terms in scientific literature databases like PubMed, Web of Science, Google Scholar, ScienceDirect, Scopus, EBSCO, ProQuest, Cochrane Library, and HighWire Press. The results are presented in different tables along with a regional comparative analysis. The study revealed that 439 taxa belonging to 89 families are used for the ethnomedical treatment of skin diseases or as cosmetics. The most commonly mentioned species are Plantago lanceolata L., Malva neglecta Wallr., Plantago major L., Juglans regia L., Hypericum perforatum L., Rubus sanctus Schreb., Urtica dioica L., Juniperus oxycedrus L., Echium italicum L., and Rosa canina L. This is the first nationwide ethnopharmacological review conducted in Türkiye for the treatment of dermatological disorders. Moreover, it is a contributing resource for further studies on using herbal remedies for the treatment of skin diseases.